These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26744873)

  • 1. Dysregulated module approach identifies disrupted genes and pathways associated with acute myelocytic leukemia.
    Fang Y; Xie LN; Liu XM; Yu Z; Kong FS; Song NX; Zhou F
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4811-26. PubMed ID: 26744873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
    Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
    Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Identification of Dysregulated Genes and Pathways in Clear Cell Renal Cell Carcinoma Based on Systematic Tracking of Disrupted Modules.
    Wang SM; Sun ZQ; Li HY; Wang J; Liu QY
    Comput Math Methods Med; 2015; 2015():313740. PubMed ID: 26543493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma.
    Zhang MH; Shen QH; Qin ZM; Wang QL; Chen X
    Oncol Lett; 2016 Nov; 12(5):3285-3295. PubMed ID: 27899995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key biomarkers involved in osteosarcoma using altered modules.
    Liu ZZ; Cui ST; Tang B; Wang ZZ; Luan ZX
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Tracking of Disrupted Modules Identifies Altered Pathways Associated with Congenital Heart Defects in Down Syndrome.
    Chen D; Zhang Z; Meng Y
    Med Sci Monit; 2015 Nov; 21():3334-42. PubMed ID: 26524729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic tracking of altered modules identifies disrupted pathways in teratozoospermia.
    Huang ZQ; Wang GX; Jiang XL; Tian EP; Yao WL; Zeng T
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic tracking of dysregulated modules identifies disrupted pathways in narcolepsy.
    Liu Z; Zhao J; Tan Y; Tang M; Li G
    Int J Clin Exp Med; 2015; 8(6):9384-93. PubMed ID: 26309600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
    Abramowitz J; Neuman T; Perlman R; Ben-Yehuda D
    BMC Med Genomics; 2017 Mar; 10(1):18. PubMed ID: 28340577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observation of significant biomarkers in osteosarcoma via integrating module- identification method with attract.
    Qi J; Ma L; Wang X; Li Y; Wang K
    Cancer Biomark; 2017 Jul; 20(1):87-93. PubMed ID: 28759958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile analysis of long non-coding RNA in acute myeloid leukemia by microarray and bioinformatics.
    Feng Y; Shen Y; Chen H; Wang X; Zhang R; Peng Y; Lei X; Liu T; Liu J; Gu L; Wang F; Yang Y; Bai J; Wang J; Zhao W; He A
    Cancer Sci; 2018 Feb; 109(2):340-353. PubMed ID: 29220122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.
    Zhao Y; Zhang X; Zhao Y; Kong D; Qin F; Sun J; Dong Y
    Med Oncol; 2015 May; 32(5):152. PubMed ID: 25832863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of AML genes in dysregulated molecular networks.
    Lee E; Jung H; Radivojac P; Kim JW; Lee D
    BMC Bioinformatics; 2009 Sep; 10 Suppl 9(Suppl 9):S2. PubMed ID: 19761572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.
    Shen H; Liang Z; Zheng S; Li X
    Int J Mol Med; 2017 Nov; 40(5):1385-1396. PubMed ID: 28949383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML.
    Ruvolo PP; Hu CW; Qiu Y; Ruvolo VR; Go RL; Hubner SE; Coombes KR; Andreeff M; Qutub AA; Kornblau SM
    EBioMedicine; 2019 Jun; 44():126-137. PubMed ID: 31105032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling and bioinformatics analysis of gastric carcinoma.
    Liu N; Liu X; Zhou N; Wu Q; Zhou L; Li Q
    Exp Mol Pathol; 2014 Jun; 96(3):361-6. PubMed ID: 24589858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of intrinsically disordered regions in hub genes of acute myeloid leukemia: A bioinformatics approach.
    Ameri M; Alipour M; Madihi M; Nezafat N
    Biotechnol Appl Biochem; 2022 Dec; 69(6):2304-2322. PubMed ID: 34812529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.